113 related articles for article (PubMed ID: 26155911)
1. VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia.
Bae MH; Oh SH; Park CJ; Lee BR; Kim YJ; Cho YU; Jang S; Lee JH; Kim N; Park SH; Lim JH; Seo EJ; Lee KH
Ann Hematol; 2015 Oct; 94(10):1631-8. PubMed ID: 26155911
[TBL] [Abstract][Full Text] [Related]
2. High CXCR4 and low VLA-4 expression predicts poor survival in adults with acute lymphoblastic leukemia.
Ko SY; Park CJ; Park SH; Cho YU; Jang S; Seo EJ; Kim N; Kim DY; Koh KN; Im HJ; Seo JJ; Chi HS
Leuk Res; 2014 Jan; 38(1):65-70. PubMed ID: 24239175
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia.
Tavernier-Tardy E; Cornillon J; Campos L; Flandrin P; Duval A; Nadal N; Guyotat D
Leuk Res; 2009 Jun; 33(6):764-8. PubMed ID: 19042019
[TBL] [Abstract][Full Text] [Related]
4. Relationship between CXC chemokine receptor 4 expression and prognostic significance in acute myeloid leukemia.
Cao T; Ye Y; Liao H; Shuai X; Jin Y; Su J; Zheng Q
Medicine (Baltimore); 2019 Jun; 98(23):e15948. PubMed ID: 31169718
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H; Nakamura N; Tomizawa D; Saito AM; Kiyokawa N; Horibe K; Nishinaka-Arai Y; Tokumasu M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
Pediatr Blood Cancer; 2016 Aug; 63(8):1394-9. PubMed ID: 27135782
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of CXCR4 in acute myeloid leukemia.
Ahn JY; Seo K; Weinberg OK; Arber DA
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):79-84. PubMed ID: 22914607
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype.
Konoplev S; Rassidakis GZ; Estey E; Kantarjian H; Liakou CI; Huang X; Xiao L; Andreeff M; Konopleva M; Medeiros LJ
Cancer; 2007 Mar; 109(6):1152-6. PubMed ID: 17315232
[TBL] [Abstract][Full Text] [Related]
8. High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.
Walter RB; Alonzo TA; Gerbing RB; Ho PA; Smith FO; Raimondi SC; Hirsch BA; Gamis AS; Franklin JL; Hurwitz CA; Loken MR; Meshinchi S
J Clin Oncol; 2010 Jun; 28(17):2831-8. PubMed ID: 20421533
[TBL] [Abstract][Full Text] [Related]
9. [Minimal residual disease detection in acute leukemia patients by flow cytometric assay of cross-lineage antigen expression].
Cho YU; Park CJ; Cha CH; Chi HS; Jang S; Kim MJ; Lee KH; Lee JH; Lee JH; Seo JJ; Im HJ
Korean J Lab Med; 2010 Dec; 30(6):533-9. PubMed ID: 21157135
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia.
Mannelli F; Cutini I; Gianfaldoni G; Bencini S; Scappini B; Pancani F; Ponziani V; Bonetti MI; Biagiotti C; Longo G; Bosi A
Cytometry B Clin Cytom; 2014 Sep; 86(5):340-9. PubMed ID: 24500843
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia.
Arellano M; Bernal-Mizrachi L; Pan L; Tighiouart M; Souza L; Guo X; McLemore M; Lima L; Sunay S; Heffner LT; Chen Z; Chen GZ; Langston A; Winton E; Khoury HJ
Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):427-32. PubMed ID: 21729688
[TBL] [Abstract][Full Text] [Related]
12. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
[TBL] [Abstract][Full Text] [Related]
13. CXC chemokine receptor 4 expression, CXC chemokine receptor 4 activation, and wild-type nucleophosmin are independently associated with unfavorable prognosis in patients with acute myeloid leukemia.
Konoplev S; Lin P; Yin CC; Lin E; Nogueras González GM; Kantarjian HM; Andreeff M; Medeiros LJ; Konopleva M
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):686-92. PubMed ID: 24035716
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
Thol F; Winschel C; Sonntag AK; Damm F; Wagner K; Chaturvedi A; Göhring G; Schlegelberger B; Lübbert M; Fiedler W; Kirchner H; Krauter J; Ganser A; Heuser M
Ann Hematol; 2013 Mar; 92(3):315-23. PubMed ID: 23233047
[TBL] [Abstract][Full Text] [Related]
15. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
16. Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.
Becker PS; Kopecky KJ; Wilks AN; Chien S; Harlan JM; Willman CL; Petersdorf SH; Stirewalt DL; Papayannopoulou T; Appelbaum FR
Blood; 2009 Jan; 113(4):866-74. PubMed ID: 18927435
[TBL] [Abstract][Full Text] [Related]
17. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.
Matsunaga T; Takemoto N; Sato T; Takimoto R; Tanaka I; Fujimi A; Akiyama T; Kuroda H; Kawano Y; Kobune M; Kato J; Hirayama Y; Sakamaki S; Kohda K; Miyake K; Niitsu Y
Nat Med; 2003 Sep; 9(9):1158-65. PubMed ID: 12897778
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 is a prognostic marker in acute myelogenous leukemia.
Spoo AC; Lübbert M; Wierda WG; Burger JA
Blood; 2007 Jan; 109(2):786-91. PubMed ID: 16888090
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
20. Expression of VLA molecules on acute leukemia cells: relationship with disease characteristics.
Vila L; Thomas X; Campos L; Sabido O; Archimbaud E
Exp Hematol; 1995 Jun; 23(6):514-8. PubMed ID: 7768307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
